ArticleThe Journal of clinical investigation2022

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo.

Shane D Falcinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.